This is a non-core endpoint: only basic statistics are computed.
Lymphangioma, anys site
CD2_BENIGN_LYMPHANGIOMA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D18
- Name in latin
- Lymphangioma (quovis hoco)
Similar endpoints
↥List of similar endpoints to
Lymphangioma, anys site
based on the number of shared cases.
Similar with more cases:
- Lymphangioma, anys site
- Haemangioma and lymphangioma, any site
- Haemangioma and lymphangioma, any site
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 286 | 176 | 110 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | 31.79 | 32.77 | 30.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 256
- Matched controls
- 2558
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D18.1
ICD-10 Finland
Lymphangioma, any site
+∞
259.7
203
*
D18.0
ICD-10 Finland
Haemangioma, any site
41.0
40.3
50
15
22701
ICD-8 Finland
Haemangioma and lymphangioma, Lymphangioma
+∞
35.2
33
*
2281A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Lymphangioma, any site
+∞
33.0
31
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
11.1
14.9
28
28
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
+∞
14.7
14
*
H02AB02
ATC
dexamethasone; systemic
21.4
12.6
18
9
130
Kela drug reimbursment
Malignant tumour
+∞
12.6
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
11.4
89
409
A04AA02
ATC
granisetron; systemic, transdermal
114.5
10.5
11
*
EP1LT
NOMESCO Finland
Percutaneous sclerotherapy of vascular malformation of head and neck
+∞
10.5
10
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
57.2
9.7
11
*
22700
ICD-8 Finland
Haemangioma and lymphangioma, Haemangioma
57.2
9.7
11
*
XX6KT
NOMESCO Finland
Other sclerotherapy
103.7
9.5
10
*
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
+∞
9.4
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.8
8.7
21
33
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
20.9
8.5
12
6
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
93.0
8.5
9
*
4704
FHL
Neck tumor removal
+∞
8.4
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
8.4
8
*
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
25.9
7.6
10
*
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
+∞
7.3
7
*
115
Kela drug reimbursment
Breast cancer
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
J01CE08
ATC
benzathine benzylpenicillin; parenteral
31.0
7.2
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.9
7.0
15
20
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
8.2
6.7
14
18
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
12.7
6.6
11
9
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
9.1
6.6
13
15
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
71.6
6.5
7
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
6.3
60
294
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
6.3
6
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
S04
ICPC
Lump/swelling localized
3.1
6.2
34
120
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
10
5
20.64
7.18
1.3
3.4
129.1
135.0
%
—
10
5
14
28
5.21
6.77
1.1
1.2
—
—
—
0
0
137
932
1.90
6.58
4.1
3.8
—
—
—
0
0
170
1242
1.91
6.54
10.2
6.3
3.9
4.1
e9/l
0.79
156
1075
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
9
11.46
5.84
1.4
2.3
113.0
123.6
%
—
10
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
9
8
11.56
5.32
2.0
1.1
86.3
114.1
%
—
9
8
128
927
1.69
4.48
8.4
6.4
1.2
1.2
mmol/l
1.20
114
795
193
1571
1.70
4.23
8.9
5.2
79.7
78.5
u/l
0.16
187
1449
9
13
7.11
4.19
1.0
1.5
8.9
9.5
umol/l
—
9
13
108
759
1.68
4.16
6.3
4.0
36.6
37.0
g/l
0.32
103
712
26
112
2.45
4.06
1.2
1.6
—
—
—
0
0
71
449
1.77
3.98
2.5
1.8
—
—
—
0
0
13
42
3.20
3.41
1.5
1.2
6.2
4.2
u/ml
—
5
19
116
876
1.55
3.14
2.7
2.5
77.5
73.6
nmol/l
0.79
109
792
8
16
5.11
3.07
1.3
1.4
—
—
—
0
0
12
41
3.01
2.89
1.3
1.1
—
—
—
0
0
28
146
2.02
2.82
7.7
6.3
5.1
5.1
kpa
0.09
23
134
27
139
2.04
2.81
8.0
6.5
0.8
1.2
mmol/l
0.24
21
100
9
24
3.84
2.69
1.0
1.3
—
—
—
0
0
33
190
1.83
2.50
16.0
18.0
1.2
1.1
inr
—
7
34
7
16
4.46
2.49
1.3
1.8
—
—
—
0
0
12
46
2.68
2.39
2.1
2.6
—
—
—
0
0
67
475
1.54
2.33
3.1
2.0
2.1
1.0
mg/l
0.48
54
353
11
41
2.75
2.30
1.6
1.2
1.2
1.5
u/ml
—
5
15
145
1199
1.42
2.29
5.0
4.5
6.3
6.5
mmol/l
0.81
137
1087
7
18
3.96
2.26
1.3
1.5
—
—
—
0
0
9
29
3.17
2.24
1.0
1.5
—
—
—
0
0
9
29
3.17
2.24
1.0
1.1
—
—
—
0
0
5
9
5.63
2.22
1.2
1.0
—
—
—
0
0
106
832
1.44
2.21
8.0
6.3
1.2
1.2
mmol/l
1.31
98
753
11
42
2.68
2.21
1.1
1.3
—
—
—
0
0
30
175
1.80
2.20
4.7
10.0
-0.0
1.0
mmol/l
0.85
22
133
41
266
1.63
2.07
1.7
1.6
—
—
—
0
0
14
63
2.29
2.04
2.1
1.7
—
—
—
0
0
10
38
2.69
2.03
1.0
1.1
—
—
—
0
0
27
157
1.79
2.01
10.5
8.4
25.5
24.8
mmol/l
0.45
27
157
9
33
2.78
1.95
1.3
1.8
—
—
—
0
0
10
39
2.62
1.94
2.6
1.5
0.3
0.5
nmol/l
—
10
33
10
39
2.62
1.94
1.4
1.7
—
—
—
0
0
32
201
1.67
1.84
3.4
4.1
1.7
1.6
mmol/l
0.06
25
152
13
60
2.22
1.80
2.1
1.6
—
—
—
0
0
90
711
1.39
1.76
4.1
3.0
27.2
34.8
ng/l
0.33
60
421
7
24
2.96
1.73
1.3
1.5
—
—
—
0
0
5
13
3.89
1.72
3.8
3.5
24.4
25.2
umol/l
—
5
13
27
165
1.70
1.72
3.7
2.7
—
—
—
0
0
24
144
1.73
1.63
2.0
1.9
82.9
72.3
ml/min/173m2
—
7
60
219
2002
1.40
1.62
13.2
8.6
88.6
88.7
ml/min/173m2
0.03
189
1566
8
33
2.46
1.55
1.3
1.5
—
—
—
0
0
8
33
2.46
1.55
1.3
1.5
—
—
—
0
0
6
21
2.90
1.51
1.0
1.1
—
—
—
0
0
248
2328
1.49
1.49
15.5
9.9
26.0
20.6
mg/l
1.37
208
1715
9
37
2.48
1.49
1.1
1.1
—
—
—
0
0
9
37
2.48
1.49
1.1
1.1
—
—
—
0
0
75
591
1.36
1.47
3.8
2.0
2.3
2.4
mmol/l
0.32
68
501
6
23
2.64
1.37
1.2
1.0
—
—
—
0
0
16
93
1.76
1.24
7.3
10.4
1.0
0.7
%
2.95
16
93
16
94
1.74
1.20
7.3
10.3
1.7
1.7
%
0.03
16
94
182
1654
1.28
1.18
4.3
3.8
10.6
9.9
mm/h
0.33
167
1505
5
20
2.53
1.15
1.0
1.1
—
—
—
0
0
5
20
2.53
1.15
1.0
1.1
—
—
—
0
0
20
128
1.60
1.12
4.0
1.9
1.2
1.2
mmol/l
0.95
20
104
14
81
1.77
1.11
1.9
2.4
38.9
42.9
u/l
0.34
14
73
239
2259
1.35
1.10
16.9
11.3
3.9
3.9
mmol/l
0.10
234
2178
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
82
683
1.28
1.08
3.4
3.1
—
—
—
0
0
15
92
1.67
0.99
3.1
2.8
0.2
0.2
e6/l
0.04
15
86
27
193
1.44
0.94
1.5
1.5
—
—
—
0
0
9
52
1.75
0.93
1.1
1.4
—
—
—
0
0
6
28
2.17
0.92
1.0
1.3
—
—
—
0
0
5
101
0.49
0.91
1.4
1.6
—
—
—
0
0
6
29
2.09
0.90
1.3
1.6
—
—
—
0
0
27
200
1.39
0.80
1.4
1.2
69.0
141.4
iu/ml
—
8
81
10
160
0.61
0.76
1.2
1.3
—
—
—
0
0
7
40
1.77
0.72
1.1
1.1
—
—
—
0
0
45
367
1.27
0.71
2.0
1.6
417.9
439.9
pmol/l
0.26
40
305
87
764
1.20
0.69
2.0
1.8
96.3
97.2
pmol/l
0.06
54
380
5
29
1.74
0.64
2.0
1.5
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
2.5
—
0
8
190
1797
1.17
0.59
4.3
3.8
14.7
14.6
pmol/l
0.35
174
1653
25
194
1.32
0.58
1.5
1.5
—
—
—
0
0
64
557
1.19
0.56
2.8
3.0
0.4
0.4
e6/l
0.05
47
399
12
82
1.48
0.55
1.6
1.4
—
—
—
0
0
17
224
0.74
0.52
1.6
1.5
—
—
—
0
0
6
40
1.51
0.52
1.2
1.3
55.0
61.8
pmol/l
—
6
40
11
155
0.70
0.50
1.2
1.5
—
—
—
0
0
218
2098
1.16
0.48
3.8
3.6
1.2
1.3
mmol/l
1.58
208
1955
56
635
0.85
0.46
1.7
1.7
—
—
—
0
0
5
81
0.61
0.46
1.2
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
1.0
—
0
11
13
97
1.36
0.40
1.5
1.5
—
—
—
0
0
191
1833
1.13
0.40
3.2
3.6
—
—
—
0
0
88
809
1.13
0.38
3.6
3.2
—
—
—
0
0
49
434
1.16
0.37
2.0
2.2
—
—
—
0
0
53
473
1.15
0.36
2.1
2.4
—
—
—
0
0
36
313
1.17
0.34
1.9
1.6
1359.8
1158.3
nmol/l
0.36
31
235
6
89
0.67
0.33
2.3
1.3
—
—
—
0
0
224
2180
1.13
0.33
4.2
3.9
1.5
1.5
mmol/l
0.37
213
2035
39
441
0.87
0.32
4.5
3.2
1.6
1.7
ug/l
0.06
34
402
10
75
1.35
0.30
1.0
1.2
0.1
3.2
u/ml
—
5
37
202
1959
1.11
0.30
5.5
5.0
38.5
38.7
mmol/mol
0.14
193
1839
72
664
1.11
0.30
1.5
1.4
2.9
1.5
u/ml
0.33
20
158
7
56
1.26
0.29
8.7
1.3
—
—
—
0
0
218
2126
1.11
0.28
4.9
4.4
1.6
2.4
mu/l
0.74
206
1971
227
2219
1.11
0.27
4.4
4.3
2.7
2.8
mmol/l
0.73
217
2072
25
217
1.17
0.25
6.4
5.7
—
—
—
0
0
6
81
0.74
0.24
2.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
11
134
0.81
0.21
1.6
1.5
—
—
—
0
0
18
155
1.17
0.20
5.7
6.0
1.8
1.3
mmol/l
0.52
18
146
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
10
122
0.81
0.19
1.9
1.9
—
—
—
0
0
10
82
1.23
0.17
1.0
1.2
—
11.9
—
0
11
8
73
1.10
0.16
1.0
1.3
—
—
—
0
0
6
76
0.79
0.16
1.0
1.2
—
—
—
0
0
7
89
0.78
0.14
1.1
1.5
—
—
—
0
0
54
571
0.93
0.14
2.0
1.6
1.2
1.4
mmol/l
0.73
49
491
225
2281
0.94
0.14
16.3
10.8
39.7
40.7
%
1.03
179
1824
26
237
1.11
0.14
4.7
3.9
33.6
31.1
%
0.65
21
157
30
277
1.09
0.13
1.6
1.9
—
—
—
0
0
112
1086
1.05
0.13
3.7
3.3
0.0
0.0
estimate
0.00
18
187
223
2201
1.06
0.12
4.3
3.9
4.6
4.7
mmol/l
0.63
214
2064
110
1068
1.05
0.12
5.5
4.5
0.0
0.0
estimate
0.00
18
192
45
428
1.06
0.10
1.5
1.5
—
—
—
0
0
43
411
1.05
0.08
1.3
1.3
10.6
23.7
iu/ml
2.12
15
119
11
123
0.89
0.08
1.5
1.4
—
—
—
0
0
11
123
0.89
0.08
1.5
1.5
—
—
—
0
0
11
123
0.89
0.08
1.5
1.5
—
—
—
0
0
11
123
0.89
0.08
1.5
1.4
—
—
—
0
0
7
67
1.05
0.08
1.1
1.4
—
—
—
0
0
39
373
1.05
0.07
3.5
3.2
22.6
181.0
ng/l
2.28
29
259
7
80
0.87
0.07
1.6
2.6
—
—
—
0
0
7
83
0.84
0.07
1.0
1.1
—
—
—
0
0
34
326
1.05
0.06
2.6
2.8
1.2
3.0
e6/l
1.92
17
165
108
1064
1.02
0.04
3.7
3.2
0.0
0.0
estimate
0.00
18
192
214
2126
1.03
0.04
4.4
3.8
5.8
5.8
mmol/l
0.03
201
1948
26
250
1.04
0.03
2.5
2.2
0.6
0.7
ug/l
1.03
15
134
34
349
0.97
0.02
3.2
3.0
16.9
24.2
%
2.11
15
120
12
113
1.06
0.02
1.8
1.3
—
—
—
0
0
27
263
1.03
0.01
1.7
1.6
—
—
—
0
0
21
216
0.97
0.00
1.4
1.8
—
—
—
0
0
35
344
1.02
0.00
2.6
2.7
1.6
0.9
e6/l
0.38
18
182
11
108
1.02
0.00
1.3
1.9
—
—
—
0
0
17
171
0.99
0.00
1.1
1.0
—
—
—
0
0
54
536
1.01
0.00
3.5
3.4
0.0
0.0
estimate
0.50
15
192
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
100.4
—
0
5
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
39
390
1.00
0.00
1.3
1.3
3.1
6.8
u/ml
0.65
17
146
7
78
0.89
0.00
1.0
1.2
—
—
—
0
0
6
59
1.02
0.00
2.0
1.6
—
0.0
—
0
10
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
23.4
—
0
6
6
59
1.02
0.00
1.5
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
1.2
—
0
6
5
53
0.94
0.00
2.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
0.00
2.2
1.3
—
105.0
—
0
9
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
11
110
1.00
0.00
1.0
1.4
270.7
284.2
miu/ml
—
5
61
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LYMPHANGIOMA_EXALLC – Lymphangioma, anys site
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).